Gilmore Neil O'Neill insider trades

Open-market stock purchases and sales by Gilmore Neil O'Neill, CEO at Editas Medicine, Inc, from SEC Form 4 filings since Jun 7, 2018.

Recent trades

DateStockTradeValue
Sep 3, 2026EDIT Editas Medicine, IncSold$15.6K
Jun 3, 2026EDIT Editas Medicine, IncSold$41.5K
Mar 12, 2026EDIT Editas Medicine, IncBought (not open market)—
Mar 3, 2026EDIT Editas Medicine, IncSold$10.9K
Dec 3, 2025EDIT Editas Medicine, IncSold$12.1K

Companies traded

  • EDIT Editas Medicine, Inc: 12 sales, last Sep 3, 2026
  • UBX Unity Biotechnology, Inc: other filings, last Jun 21, 2024
  • APTX Aptinyx Inc: other filings, last May 26, 2022
  • SRPT Sarepta Therapeutics, Inc: other filings, last Mar 3, 2021

Get free alerts when Gilmore Neil O'Neill files a new trade →